ARIGEN PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 98
ARIGEN PHARMACEUTICALS, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include T. The owner is based in MINATO-KU, TOKYO.
PLACE CANADA 3F
MINATO-KU, TOKYO , JP
Showing of trademarks Trademarks
Trademark Classifications
ARIGEN PHARMACEUTICALS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does ARIGEN PHARMACEUTICALS, INC. have?
ARIGEN PHARMACEUTICALS, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.
What trademark classes does ARIGEN PHARMACEUTICALS, INC. file in?
ARIGEN PHARMACEUTICALS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ARIGEN PHARMACEUTICALS, INC.'s most well-known trademarks?
ARIGEN PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as T. These are among 1 currently registered trademark in the portfolio.
What is ARIGEN PHARMACEUTICALS, INC.'s trademark registration success rate?
ARIGEN PHARMACEUTICALS, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.